Partnership
Assessment of gene therapy delivery methods for models of neuroinflammation
Dates
1 Jan, 2024
-
31 Dec, 2026
Partnership types
Research
Monetary value
£125,391.70
The total amount of money allotted to the whole project, not necessarily the amount of money that was recieved by a specific university.
Description
The project aims to develop engineered genetic control systems and enhanced delivery vehicles to ensure gene therapies express transgenes in the correct tissue, at the right level, and for the optimal duration in neuroinflammatory models.Universities
All universities involved in the partnership
Funders
Either the direct backers, or the institutions through which funding was distributed.
Defence Science & Technology Laboratory (DSTL)
Military Partners
Companies or government departments involved in the provision of military goods or services
Other Partners
Companies or government departments involved in the provision of military goods or services
Data sources
Date of research collection
Nov. 13, 2025
Source
FOI Request 2025-08-13